Hye-yeon Park

4 Patents

• US123656902025

  Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1h-cyclopenta[b]pyridine-3-carboxylate and Methyl 2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyrodine-3-carboxylate as Ca V 1.2 Activators

  Novartis AG

  0 cites
• US119199112024

  Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1h-cyclopenta[b]pyridine-3-carboxylate and Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate as CAV1.2 Activators

  Novartis AG

  0 cites
• US116074332023

  Composition for Preventing, Improving, or Treating Autism Spectrum Disorders Including Agathobaculum Sp. Strain as Active Ingredient

  HEALTHBIOME

  0 cites
• US115424682023

  Agathobaculum Sp. Strain Having Prophylactic or Therapeutic Effects on Degenerative Brain Diseases and Use Thereof

  HEALTHBIOME

  0 cites